[ad_1] NEW DELHI: The Centre has come up with a game-changer special initiative by manufacturing four types of homegrown ‘Made in India‘ drugs for rare diseases for the first time.The Central Government has prioritised 13 rare diseases and sickle cell disease. The most awaited initiative was taken in July 2022 …
Read More »